Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?

Zraika, S; Hull, R L; Verchere, C B; Clark, A; Potter, K J; Fraser, P E; Raleigh, D P; Kahn, S E

Zraika, S; Hull, R L; Verchere, C B; Clark, A; Potter, K J; Fraser, P E; Raleigh, D P; Kahn, S E.

Affiliation

Zraika S; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, 1660 South Columbian Way (151), Seattle, WA 98108, USA. zraikas@u.washington.edu

Diabetologia ; 53(6): 1046-56, 2010 Jun.

Article in En | MEDLINE | ID: mdl-20182863

Subject(s)

Amyloidosis/pathology; Diabetes Mellitus, Type 2/etiology; Insulin-Secreting Cells/pathology; Cell Death; Diabetes Mellitus, Type 2/pathology; Humans; Pancreatic Diseases/etiology; Pancreatic Diseases/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Insulin-Secreting Cells / Amyloidosis Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Diabetologia Year: 2010 Document type: Article Affiliation country: United States Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google